ULTOMIRIS® (ravulizumab-cwvz)

Please see the full Prescribing Information (Ultomiris.com/PI) and Medication Guide (Ultomiris.com/MedGuide) for ULTOMIRIS, including Boxed WARNING regarding serious meningococcal infections.

To report SUSPECTED SIDE EFFECTS, contact Alexion Pharmaceuticals, Inc. at 1-844-259-6783 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Intended for US audiences only. Please click the “Playlists” tab to find videos organized by condition.

ALEXION, the Alexion logo, ULTOMIRIS, and SOLIRIS are registered trademarks of Alexion Pharmaceuticals, Inc. © 2024, Alexion Pharmaceuticals, Inc. All rights reserved. US/ALL/1177 V1 10/2024